Martijn B. Busstra

1.0k total citations
32 papers, 493 citations indexed

About

Martijn B. Busstra is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Martijn B. Busstra has authored 32 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 7 papers in Oncology. Recurrent topics in Martijn B. Busstra's work include Prostate Cancer Diagnosis and Treatment (21 papers), Prostate Cancer Treatment and Research (19 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Martijn B. Busstra is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (21 papers), Prostate Cancer Treatment and Research (19 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Martijn B. Busstra collaborates with scholars based in Netherlands, Greece and United States. Martijn B. Busstra's co-authors include Monique J. Roobol, Chris H. Bangma, Geert J.L.H. van Leenders, Henk G. van der Poel, Simone U. Dalm, Θεοδοσία Μάινα, Wytske M. van Weerden, Berthold A. Nock, Rosalba Mansi and Ellen C. Zwarthoff and has published in prestigious journals such as The Journal of Urology, European Urology and European Journal of Cancer.

In The Last Decade

Martijn B. Busstra

31 papers receiving 487 citations

Peers

Countries citing papers authored by Martijn B. Busstra

Since Specialization

Citations

This map shows the geographic impact of Martijn B. Busstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martijn B. Busstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martijn B. Busstra more than expected).

Fields of papers citing papers by Martijn B. Busstra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martijn B. Busstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martijn B. Busstra. The network helps show where Martijn B. Busstra may publish in the future.

Co-authorship network of co-authors of Martijn B. Busstra

This figure shows the co-authorship network connecting the top 25 collaborators of Martijn B. Busstra. A scholar is included among the top collaborators of Martijn B. Busstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martijn B. Busstra. Martijn B. Busstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Experience of urologists, oncologists and nurse practitioners with mainstream genetic testing in metastatic prostate cancer 2024 ·Prostate Cancer and Prostatic Diseases ·(unknown), Margreet G.E.M. Ausems, Lambertus A. Kiemeney, (unknown), Harm H.E. van Melick, (unknown), Diederik M. Somford, Henk G. van der Poel, Carl Wijburg, (unknown), (unknown), R. Jeroen A. van Moorselaar, (unknown), Richard P. Meijer, Martijn B. Busstra, H. Pieter van den Berg, Debbie Robbrecht, (unknown), Eveline M. A. Bleiker, Inge M. van Oort	1
2	Centralized prostatectomy with intraoperative NeuroSAFE margin assessment improves surgical margin control 2024 ·Histopathology ·(unknown), Sebastiaan Remmers, Martijn B. Busstra, M. Gan, Sjoerd Klaver, John Rietbergen, (unknown), Eva Hollemans, Charlotte F. Kweldam, Chris H. Bangma, Monique J. Roobol, Geert J.L.H. van Leenders	1
3	Biopsy prostate cancer perineural invasion and tumour load are associated with positive posterolateral margins at radical prostatectomy: implications for planning of nerve‐sparing surgery 2023 ·Histopathology ·(unknown), Sebastiaan Remmers, Charlotte F. Kweldam, Michael A. den Bakker, Daan Nieboer, Martijn B. Busstra, M. Gan, Sjoerd Klaver, John Rietbergen, Geert J.L.H. van Leenders, (unknown)	4
4	Does Centralization of Radical Prostatectomy Reduce the Incidence of Postoperative Urinary Incontinence? 2023 ·European Urology Open Science ·(unknown), Miranda L. van Hooff, Onno van der Galiën, (unknown), Diederik M. Somford, Pim J. van Leeuwen, Martijn B. Busstra, Sjoerd Repping, Michel W.J.M. Wouters, Jacques van Limbeek	3
5	Urinary Incontinence and Sexual Function After the Introduction of NeuroSAFE in Radical Prostatectomy for Prostate Cancer 2023 ·European Urology Focus ·(unknown), Sebastiaan Remmers, Geert J.L.H. van Leenders, Martijn B. Busstra, M. Gan, Sjoerd Klaver, John Rietbergen, Michael A. den Bakker, Charlotte F. Kweldam, Chris H. Bangma, Monique J. Roobol, Lionne D. F. Venderbos	14
6	Lymphoceles after pelvic lymph node dissection during robot-assisted radical prostatectomy 2023 ·Translational Andrology and Urology ·(unknown), (unknown), (unknown), Lionne D. F. Venderbos, Geert J.L.H. van Leenders, Monique J. Roobol, Martijn B. Busstra	1
7	Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern 2022 ·World Journal of Urology ·(unknown), (unknown), Charlotte F. Kweldam, Michael A. den Bakker, Martijn B. Busstra, M. Gan, Sjoerd Klaver, John Rietbergen, Geert J.L.H. van Leenders	5
8	GRPr Antagonist ⁶⁸Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve Patients 2021 ·Journal of Nuclear Medicine ·(unknown), (unknown), Martijn B. Busstra, J. Fred Verzijlbergen, Mark Konijnenberg, Geert J.L.H. van Leenders, Ivo G. Schoots, Erik de Blois, Wytske M. van Weerden, Simone U. Dalm, Θεοδοσία Μάινα, Berthold A. Nock, Marion de Jong	31
9	Comparison of 68Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Primary Staging of Prostate Cancer: A Systematic Review and Meta-analysis 2021 ·European Urology Open Science ·(unknown), (unknown), Ivo G. Schoots, Kazem Nasserinejad, Martijn B. Busstra, Astrid A.M. van der Veldt, Tessa Brabander	12
10	Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in the Evaluation of Initial Response in Candidates Who Underwent Salvage Radiation Therapy after Radical Prostatectomy for Prostate Cancer 2020 ·The Journal of Urology ·Dennie Meijer, (unknown), Pim J. van Leeuwen, Sebastiaan Remmers, B.H.E. Jansen, Yves J. L. Bodar, (unknown), Eva E. Schaake, Henk G. van der Poel, Maurits Wondergem, Martijn B. Busstra, Jakko A. Nieuwenhuijzen, Philip Meijnen, Tessa Brabander, R. Jeroen A. van Moorselaar, N. Harry Hendrikse, Daniela E. Oprea‐Lager, Monique J. Roobol, André N. Vis	4
11	Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study 2019 ·European Urology Focus ·(unknown), Floris J. Pos, Maarten C.C.M. Hulshof, Robin W.M. Vernooij, (unknown), George van Andel, (unknown), (unknown), Martijn B. Busstra, R. Jeroen A. van Moorselaar, Christina A. Hulsbergen‐van de Kaa, Geert J.L.H. van Leenders, Paul Hamberg, Franchette van den Berkmortel, Jurgen J. Fütterer, Lambertus A. Kiemeney, Inge M. van Oort, Katja K.H. Aben	8
12	[Incidence of incontinence after radical prostatectomy using claims-based data]. 2018 ·PubMed ·(unknown), (unknown), Diederik M. Somford, (unknown), R.G.H.M. Cremers, S. de Vries, Katja K.H. Aben, (unknown), (unknown), (unknown), Martijn B. Busstra, Jacques van Limbeek	4
13	Hoe vaak incontinentie na radicale prostatectomie 2018 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·(unknown), (unknown), Diederik M. Somford, (unknown), R.G.H.M. Cremers, (unknown), Katja K.H. Aben, (unknown), (unknown), (unknown), Martijn B. Busstra, Jacques van Limbeek	1
14	Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors 2018 ·Prostate Cancer and Prostatic Diseases ·(unknown), Inge M. van Oort, George van Andel, (unknown), Floris J. Pos, Maarten C.C.M. Hulshof, Christina A. Hulsbergen‐van de Kaa, Geert J.L.H. van Leenders, Jurgen J. Fütterer, (unknown), Martijn B. Busstra, R. Jeroen A. van Moorselaar, Lambertus A. Kiemeney, Katja K.H. Aben	3
15	Outcomes of a Bladder Cancer Screening Program Using Home Hematuria Testing and Molecular Markers 2013 ·European Urology ·Chris H. Bangma, Stacy Loeb, Martijn B. Busstra, Xiaoye Zhu, Samira El Bouazzaoui, (unknown), Kirstin A. van der Keur, (unknown), (unknown), Geert J.L.H. van Leenders, Ellen C. Zwarthoff, Monique J. Roobol	40
16	Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort 2012 ·European Journal of Cancer ·(unknown), Ries Kranse, Ewout W. Steyerberg, Henk G. van der Poel, Martijn B. Busstra, Paul J.M. Kil, Eric H. G. M. Oomens, Igle J. de Jong, Chris H. Bangma, Monique J. Roobol	27
17	Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study 2011 ·British Journal of Urology ·(unknown), Monique J. Roobol, Henk G. van der Poel, (unknown), Martijn B. Busstra, P. Kil, Eric H. G. M. Oomens, Anna M. Leliveld, Chris H. Bangma, Ida J. Korfage, Ewout W. Steyerberg	12
18	Compliance with biopsy recommendations of a prostate cancer risk calculator 2011 ·British Journal of Urology ·(unknown), Monique J. Roobol, Martijn B. Busstra, P. Kil, Eric H. G. M. Oomens, Igle J. de Jong, Chris H. Bangma, Ewout W. Steyerberg, Ida J. Korfage	22
19	In-depth investigation of the molecular pathogenesis of bladder cancer in a unique 26-year old patient with extensive multifocal disease: a case report 2010 ·BMC Urology ·Tahlita C.M. Zuiverloon, Cheno Abas, Kirstin A. van der Keur, Marcel Vermeij, (unknown), (unknown), Martijn B. Busstra, Ellen C. Zwarthoff	5
20	A phase II study of temozolomide in hormone-refractory prostate cancer 2000 ·Cancer Chemotherapy and Pharmacology ·J.P. van Brussel, Martijn B. Busstra, Margreet Lang, (unknown), Fritz H. Schröder, G. Mickisch	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact